INDICATIONS:
1. OPEN-ANGLE GLAUCOMA; DEMECARIUM SHOULD BE USED IN GLAUCOMA ONLY WHEN SHORTER-ACTING MIOTICS HAVE PROVED INADEQUATE.
2. CONDITIONS OBSTRUCTING AQUEOUS OUTFLOW, SUCH AS SYNECHIAL FORMATION, THAT ARE AMENABLE TO MIOTIC THERAPY
3. FOLLOWING IRIDECTOMY
4. ACCOMMODATIVE ESOTROPIA (ACCOMMODATIVE CONVERGENT STRABISMUS)
THE PATIENT MUST BE CLOSELY OBSERVED DURING THE INITIAL PERIOD. IF THE RESPONSE IS NOT ADEQUATE WITHIN THE FIRST 24 HOURS, OTHER MEASURES SHOULD BE CONSIDERED.
KEEP FREQUENCY OF USE TO A MINIMUM IN ALL PATIENTS, BUT ESPECIALLY IN CHILDREN, TO REDUCE THE CHANCE OF IRIS CYST DEVELOPMENT
A DECREASE IN INTRAOCULAR PRESSURE SHOULD OCCUR WITHIN A FEW HOURS. DURING THIS PERIOD, KEEP THE PATIENT UNDER SUPERVISION AND MAKE TONOMETRIC EXAMINATIONS AT LEAST HOURLY FOR 3 OR 4 HOURS TO BE SURE THAT NO IMMEDIATE RISE IN PRESSURE OCCURS.
DURATION OF EFFECT VARIES WITH THE INDIVIDUAL. THE USUAL DOSAGE CAN VARY FROM AS MUCH AS 1 OR 2 DROPS TWICE A DAY TO AS LITTLE AS 1 OR 2 DROPS TWICE A WEEK.